[Federal Register Volume 64, Number 80 (Tuesday, April 27, 1999)]
[Notices]
[Pages 22612-22613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-10467]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee (NVAC), Subcommittee on
Future Vaccines, Subcommittee on Immunization Coverage, and
Subcommittee on Vaccine Safety: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
NAME: National Vaccine Advisory Committee (NVAC).
TIMES AND DATES: 9 a.m.-2 p.m., May 13, 1999; 8:30 a.m.-1 p.m., May 14,
1999.
PLACE: Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue,
SW, Washington, DC 20201.
STATUS: Open to the public, limited only by the space available.
NOTICE: In the interest of security, the Department has instituted
stringent procedures for entrance to the Hubert H. Humphrey Building by
non-government employees. Thus, persons without a government
identification card should plan to arrive at the building each day
either between 8 and 8:30 a.m. or 12:30 and 1 p.m. so they can be
escorted to the meeting. Entrance to the meeting at other times during
the day cannot be assured.
PURPOSE: This committee advises and makes recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
MATTERS TO BE DISCUSSED: Agenda items will include updates on the
National Vaccine Program Office (NVPO) activities. There will be a
report from the Institute of Medicine on Vaccine Priorities. There will
be discussions on: The international measles control and elimination
efforts; update on the Advisory Committee on Immunization Practices
(ACIP) activities; update on general principles of Vaccine For Children
Program (VFC); there will be a follow-up on immunization
infrastructure; a discussion on the impact of new vaccines on anti-
microbial use. There will be a report from the Assistant Secretary for
Health and Surgeon General, update on Healthy People 2010 objectives;
an update on pneumococcal and influenza morbidity and mortality. There
will be discussions on: Pandemic influenza planning and global vaccine
initiatives. There will be
[[Page 22613]]
reports from the Subcommittee on Future Vaccines, Subcommittee on
Immunization Coverage, and the Subcommittee on Vaccine Safety.
NAME: Subcommittee on Immunization Coverage.
TIME AND DATE: 2 p.m.-5 p.m., May 13, 1999.
PLACE: Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue,
SW, Washington, DC 20201.
STATUS: Open to the public, limited only by the space available.
PURPOSE: This subcommittee will identify and propose solutions that
provide a multifaceted and holistic approach to reducing barriers that
result in low immunization coverage for children.
MATTERS TO BE DISCUSSED: This subcommittee will discuss: adult
immunization in non-traditional settings; revisions of the Standards on
Adult Immunization; the status of activities to sustain immunization
coverage, an update on morbidity and mortality for influenza and
pneumococcal disease; draft guidelines for implementation of new
vaccines; the Children's Health Insurance Program (CHIP); and a draft
statement on adolescent immunizations.
NAME: Subcommittee on Future Vaccines.
TIME AND DATE: 2 p.m.-5 p.m., May 13, 1999.
PLACE: Hubert H. Humphrey Building, Room 305, 200 Independence Avenue,
SW, Washington, DC 20201.
STATUS: Open to the public, limited only by the space available.
PURPOSE: The Subcommittee on Future Vaccines will develop policy
options and guide national activities which will lead to accelerated
development, licensure, and best use of new vaccines in the simplest
possible immunization schedules.
MATTERS TO BE DISCUSSED: This subcommittee will hold discussions
regarding the IOM report on vaccines priorities.
There will be a discussion on orphan vaccines and global vaccines,
and an update on the status of the paper ``Lessons Learned From A
Review Of The Development Of Selected Vaccines''.
NAME: Subcommittee on Vaccine Safety.
TIME AND DATE: 2 p.m.-5 p.m., May 13, 1999.
PLACE: Hubert H. Humphrey Building, Room 325, 200 Independence Avenue,
SW, Washington, DC 20201.
STATUS: Open to the public, limited only by the space available.
PURPOSE: This subcommittee will review issues relevant to vaccine
safety and adverse reactions to vaccines.
MATTERS TO BE DISCUSSED: This subcommittee will discuss the mission of
the Vaccine Safety Subcommittee, developing priorities for the Vaccine
Safety Action Plan. There will be a discussion on the DHHS
Communication Coalition. Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION: Felecia D. Pearson, Committee
Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S A11,
Atlanta, Georgia 30333, telephone 404/639-4450.
Director, Management Analysis Services Office, has been delegated
the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: April 21, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 99-10467 Filed 4-26-99; 8:45 am]
BILLING CODE 4163-18-P
